Long-term followup of patients treated with total lymphoid irradiation for lupus nephritis

Arthritis and Rheumatism

Volumn 46, Issue 4, 2002, Pages 1014-1018

  Genovese, Mark C ^a   Uhrin, Zuzana ^a   Bloch, Daniel A ^a   Oehlert, John ^a   Sibley, Richard K ^a   Myers, Bryan ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG MEGADOSE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPH NODE IRRADIATION; MALE; MALIGNANT NEOPLASTIC DISEASE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS NEPHRITIS; LYMPHATIC IRRADIATION; MALE; NEOPLASMS; OPPORTUNISTIC INFECTIONS; PROTEINURIA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036222911     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10216     Document Type: Article

References (18)

1. Total lymphoid irradiation
2. Treatment of rheumatoid arthritis with total lymphoid irradiation: Long-term survival
3. Effect of total lymphoid irradiation on levels of serum autoantibodies in systemic lupus erythematosus and in rheumatoid arthritis
4. Modified total lymphoid irradiation and low dose corticosteroids in progressive multiple sclerosis
5. Treatment of intractable lupus nephritis with total lymphoid irradiation
6. Treatment of lupus nephritis with total lymphoid irradiation: Observations during a 12-79-month followup
7. Lupus nephritis after total lymphoid irradiation: Persistent improvement and reduction of steroid therapy
8. Outcome of the acute glomerular injury in proliferative lupus nephritis
9. Total lymphoid irradiation in refractory systemic lupus erythematosus
10. Treatment of lupus nephritis: A meta-analysis of clinical trials
11. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only
12. Methyl-prednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis: A randomized, controlled trial
13. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
14. The 1982 revised criteria for the classification of systemic lupus erythematosus
15. Treatment of lupus nephritis
16. Immunoablative high-dose cyclophosphamide without stemcell rescue for refractory, severe autoimmune disease
17. Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data
18. Clinical, biochemical, and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis